相关实验视频

Updated: Jun 22, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

SLC16A3是一种预后标记物,影响膀癌中的免疫调节

Chengjun Li¹, Guangdi Chu¹, Guofeng Ma¹

¹Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Combinatorial chemistry & high throughput screening

|July 3, 2024

概括

在膀癌 (BC) 中,高SLC16A3表达与预后不佳相关,并影响免疫透. SLC16A3可以作为BC检测和治疗的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症新陈代谢癌症新陈代谢

背景情况:

溶性载体家族16成员3 (SLC16A3) 的过度表达通过调节新陈代谢与瘤的发展有关.
有限的研究存在于SLC16A3在膀癌 (BC) 中的作用.

研究的目的:

系统地分析SLC16A3表达及其在膀癌中的临床意义.
调查SLC16A3之间关系,新陈代谢,m6A修饰和BC中的免疫透.

主要方法:

利用公开的BC数据集进行表达分析和与临床特征的相关性.
使用R包进行了基因功能,免疫相关性,免疫疗法和药物敏感性分析.
通过单细胞测序研究SLC16A3表达局部化,并通过RT-qPCR和IHC验证了蛋白质/RNA表达.

主要成果:

在BC细胞中,SLC16A3显著过度表达,与患者预后不佳相关.
建立了基于SLC16A3表达的BC患者可靠的预后模型.
在SLC16A3,m6A修饰 (ALKBH5),有氧糖解基因,M2巨菌透和免疫检查点之间发现了显著的关联.

结论:

过度表达SLC16A3是膀癌的独立预后因素.
通过通过代谢和m6A甲基化调节影响免疫透,SLC16A3可能会促进BC进展.
SLC16A3为BC检测和治疗提供了潜在的治疗点.

关键词:

膀癌是一种癌症.免疫透免疫透是什么?m6A 修改的修改预后. 预后. 这是一个预后.溶解物载体家族16个成员3个成员3个成员

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...